Extended storage of SARS-CoV-2 nasopharyngeal swabs does not negatively impact results of molecular-based testing across three clinical platforms
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ..
With the global outbreak of COVID-19, the demand for testing rapidly increased and quickly exceeded the testing capacities of many laboratories. Clinical tests which receive CE (Conformité Européenne) and Food and Drug Administration (FDA) authorisations cannot always be tested thoroughly in a real-world environment. Here we demonstrate the long-term stability of nasopharyngeal swab specimens for SARS-CoV-2 molecular testing across three assays recently approved by the US FDA under Emergency Use Authorization. This study demonstrates that nasopharyngeal swab specimens can be stored under refrigeration or even ambient conditions for 21 days without clinically impacting the results of the real-time reverse transcriptase-PCR testing.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:75 |
|---|---|
| Enthalten in: |
Journal of clinical pathology - 75(2022), 1 vom: 03. Jan., Seite 61-64 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Skalina, Karin A [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Hospital |
|---|
| Anmerkungen: |
Date Completed 12.01.2022 Date Revised 12.01.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1136/jclinpath-2020-206738 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM317126164 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM317126164 | ||
| 003 | DE-627 | ||
| 005 | 20231225162604.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/jclinpath-2020-206738 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1057.xml |
| 035 | |a (DE-627)NLM317126164 | ||
| 035 | |a (NLM)33144357 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Skalina, Karin A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Extended storage of SARS-CoV-2 nasopharyngeal swabs does not negatively impact results of molecular-based testing across three clinical platforms |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 12.01.2022 | ||
| 500 | |a Date Revised 12.01.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. | ||
| 520 | |a With the global outbreak of COVID-19, the demand for testing rapidly increased and quickly exceeded the testing capacities of many laboratories. Clinical tests which receive CE (Conformité Européenne) and Food and Drug Administration (FDA) authorisations cannot always be tested thoroughly in a real-world environment. Here we demonstrate the long-term stability of nasopharyngeal swab specimens for SARS-CoV-2 molecular testing across three assays recently approved by the US FDA under Emergency Use Authorization. This study demonstrates that nasopharyngeal swab specimens can be stored under refrigeration or even ambient conditions for 21 days without clinically impacting the results of the real-time reverse transcriptase-PCR testing | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a hospital | |
| 650 | 4 | |a microbiology | |
| 650 | 4 | |a pathology department | |
| 650 | 4 | |a polymerase chain reaction | |
| 650 | 4 | |a virology | |
| 700 | 1 | |a Goldstein, D Y |e verfasserin |4 aut | |
| 700 | 1 | |a Sulail, Jaffar |e verfasserin |4 aut | |
| 700 | 1 | |a Hahm, Eunkyu |e verfasserin |4 aut | |
| 700 | 1 | |a Narlieva, Momka |e verfasserin |4 aut | |
| 700 | 1 | |a Szymczak, Wendy |e verfasserin |4 aut | |
| 700 | 1 | |a Fox, Amy S |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical pathology |d 1947 |g 75(2022), 1 vom: 03. Jan., Seite 61-64 |w (DE-627)NLM000031372 |x 1472-4146 |7 nnns |
| 773 | 1 | 8 | |g volume:75 |g year:2022 |g number:1 |g day:03 |g month:01 |g pages:61-64 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1136/jclinpath-2020-206738 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 75 |j 2022 |e 1 |b 03 |c 01 |h 61-64 | ||